CD59 and CD48 expressed by rat retinal pigment epithelial cells are major ligands for the CD2-mediated alternative pathway of T cell activation. 1996

J Liversidge, and R Dawson, and S Hoey, and D McKay, and P Grabowski, and J V Forrester
Department of Ophthalmology, University of Aberdeen Medical School, Scotland, United Kingdom.

The alternative CD2-mediated pathway of T cell activation, which is independent of MHC/peptide recognition by the TCR/CD3 complex, is dependent upon two signals being received by the CD2 molecule. The natural ligand for CD2 is CD58, but controversy exists over alternative or additional ligands that could deliver the second signal in vivo. We have used rat retinal pigment epithelial cells (RPE), which lack temperature-insensitive ligands for CD2 adhesion, to study Ag-independent T cell activation. Rat RPE cells expressed high levels of CD59 and low levels of another potential CD2 ligand, CD48, both in vitro and in the in vivo model of experimental autoimmune uveoretinitis. When increasing numbers of syngeneic T cells were added to microwell cultures of rat RPE cells, the T cells, even in the absence of any exogenous stimulant in the cultures, underwent spontaneous proliferation. This effect required metabolically active RPE cells, and was IL-2 driven and enhanced in the presence of indomethacin. Proliferation was modulated by phosphatidylinositol-phospholipase C treatment of the RPE, and blocked by mAbs to CD59. Ab cross-linking of CD48 but not CD59 on the RPE was found to induce messenger RNA expression for IL-1 beta, which together with constitutively expressed IL-6 are required costimulatory factors for T cell activation through CD2. This is the first demonstration in a fully syngeneic system that bi-directional signaling involving CD59 and CD48 molecules expressed by physiologically normal, nonhematopoietic, cells can trigger T lymphocyte activation and proliferation through autocrine IL-2 production in the absence of Ag.

UI MeSH Term Description Entries
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010727 Phosphoric Diester Hydrolases A class of enzymes that catalyze the hydrolysis of one of the two ester bonds in a phosphodiester compound. EC 3.1.4. Phosphodiesterase,Phosphodiesterases,Hydrolases, Phosphoric Diester
D010857 Pigment Epithelium of Eye The layer of pigment-containing epithelial cells in the RETINA; the CILIARY BODY; and the IRIS in the eye. Eye Pigment Epithelium
D011917 Rats, Inbred Lew An inbred strain of rat that is used in BIOMEDICAL RESEARCH. Rats, Inbred Lewis,Rats, Lew,Inbred Lew Rat,Inbred Lew Rats,Inbred Lewis Rats,Lew Rat,Lew Rat, Inbred,Lew Rats,Lew Rats, Inbred,Lewis Rats, Inbred,Rat, Inbred Lew,Rat, Lew
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D000071178 CD48 Antigen A 40-45 KDa GPI-linked protein in the SLAM family that consists of two IMMUNOGLOBULIN C2-SET DOMAINS. It is expressed on the surface of a variety of cells with immune functions, including THYMOCYTES; mature B-LYMPHOCYTES and T-LYMPHOCYTES; NATURAL KILLER CELLS; DENDRITIC CELLS; MAST CELLS; and EOSINOPHILS. It binds to CD2 and 2B4 (CD244) receptors to activate and modulate the immunologic response. B-Lymphocyte Activation Marker BLAST-1,BCM1 Surface Antigen,Blast1 Antigen,Leukocyte Antigen MEM-102,MRC OX-45 Antigen,P41 Antigen,SLAM Family Member 2,SLAMF2 Protein,Signal-Transducing Glycoprotein-60,Signaling Lymphocytic Activation Molecule 2,Signaling Lymphocytic Activation Molecule Family Member 2,Antigen, CD48,Antigen, MRC OX-45,Antigen, P41,B Lymphocyte Activation Marker BLAST 1,Glycoprotein-60, Signal-Transducing,Leukocyte Antigen MEM 102,MEM-102, Leukocyte Antigen,MRC OX 45 Antigen,Signal Transducing Glycoprotein 60,Surface Antigen, BCM1
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

J Liversidge, and R Dawson, and S Hoey, and D McKay, and P Grabowski, and J V Forrester
August 2022, Science immunology,
J Liversidge, and R Dawson, and S Hoey, and D McKay, and P Grabowski, and J V Forrester
January 1987, Nature,
J Liversidge, and R Dawson, and S Hoey, and D McKay, and P Grabowski, and J V Forrester
June 1990, Journal of immunology (Baltimore, Md. : 1950),
J Liversidge, and R Dawson, and S Hoey, and D McKay, and P Grabowski, and J V Forrester
January 2015, Investigative ophthalmology & visual science,
J Liversidge, and R Dawson, and S Hoey, and D McKay, and P Grabowski, and J V Forrester
January 1995, Current biology : CB,
J Liversidge, and R Dawson, and S Hoey, and D McKay, and P Grabowski, and J V Forrester
November 1992, The Journal of experimental medicine,
J Liversidge, and R Dawson, and S Hoey, and D McKay, and P Grabowski, and J V Forrester
September 1988, The Journal of experimental medicine,
J Liversidge, and R Dawson, and S Hoey, and D McKay, and P Grabowski, and J V Forrester
December 1998, European journal of immunology,
J Liversidge, and R Dawson, and S Hoey, and D McKay, and P Grabowski, and J V Forrester
September 1996, The Journal of membrane biology,
J Liversidge, and R Dawson, and S Hoey, and D McKay, and P Grabowski, and J V Forrester
December 2015, The Journal of biological chemistry,
Copied contents to your clipboard!